Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer
2012 ◽
Vol 82
(4)
◽
pp. e609-e615
◽
2020 ◽
Vol 5
(3)
◽
pp. 396-403
◽
2016 ◽
Vol 1
(4)
◽
pp. 300-309
◽
2018 ◽
Vol 102
(3)
◽
pp. S146
◽
2016 ◽
Vol 94
(2)
◽
pp. 263-271
◽
2017 ◽
Vol 99
(2)
◽
pp. E250-E251
2016 ◽
Vol 96
(2)
◽
pp. S33
◽
2009 ◽
Vol 91
(2)
◽
pp. 237-242
◽
2018 ◽
Vol 102
(3)
◽
pp. e147-e148
◽
2013 ◽
Vol 87
(2)
◽
pp. S364